Neuland Laboratories Limited (NEULANDLAB) — Announcement
Neuland Laboratories announced its participation in the Nuvama India Conference 2026 in London on June 8-9, 2026, offering group and one-on-one meetings with analysts and institutional investors. The filing confirms the event dates and location but notes the schedule may change due to participant or company exigencies, signaling proactive engagement with global investors ahead of potential strategic updates.
About Neuland Laboratories Limited (NEULANDLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when NEULANDLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NEULANDLAB — Free💡 Ask AI about this filing
📊 More NEULANDLAB filings
- share transfer — 2 July 2026 Neuland Laboratories Limited received a SEBI-mandated certificate from its share transfer agent, Kfi...
- Financial Results — 25 June 2026 Neuland Laboratories Limited announced that its trading window will close on July 1, 2026, and remai...
- Announcement — 31 May 2026 Neuland Laboratories announced its management will attend a BOFA Healthcare Tour investor meeting in...
- Announcement — 22 May 2026 Neuland Laboratories announced its management will attend the 16th Annual Investor Conference hosted...
- 🔴 Financial Results — 16 May 2026 Neuland Laboratories reported FY26 revenue of **₹2,053.1 crores**, up 37.1% YoY, with EBITDA margin ...
🔥 Also filed on 3 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when NEULANDLAB files new disclosures
Track NEULANDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NEULANDLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research